Takahashi, H., Fukuokaya, W., Yanagisawa, T., Okamoto, M., Urabe, F., Mori, K., . . . Kimura, T. (2026). Efficacy and safety of first-line immune checkpoint inhibitor–based combination therapy in metastatic renal cell carcinoma patients on hemodialysis. Urologic Oncology, 44(9), 451-460.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Takahashi, Hidetsugu, et al. "Efficacy and Safety of First-line Immune Checkpoint Inhibitor–based Combination Therapy in Metastatic Renal Cell Carcinoma Patients on Hemodialysis."
Urologic Oncology 44, no. 9 (2026): 451-460.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Takahashi, Hidetsugu, et al. "Efficacy and Safety of First-line Immune Checkpoint Inhibitor–based Combination Therapy in Metastatic Renal Cell Carcinoma Patients on Hemodialysis."
Urologic Oncology, vol. 44, no. 9, 2026, pp. 451-460.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.